Nos experts témoignent

Ulrick Birba,
Technicien principal du laboratoire de thérapie cellulaire

21 october 2021

Gustave Roussy and LXRepair announce a partnership for personalized radiotherapy of cancer

PLXRepair, a pioneer in personalized radiotherapy with functional assays measuring DNA repair to predict treatment response, with a clinical proof-of-concept of radiotoxicity prediction in breast and prostate cancer, and Gustave Roussy, Europe's leading cancer center, announced today the launch of a joint laboratory to improve the personalization of radiotherapy.

Villejuif, le 14 octobre 2021

Octobre rose // Tout n’est pas rose

Villejuif, 05 october 2021

SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe

Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug testing, 3D tumor cell culture, and AI analytics established at SEngine Precision Medicine to identify the best personalized therapeutic matches for patients

Villejuif, le 4 octobre 2021

Odysséa Paris 2021 collecte 472 000 euros pour la recherche contre le cancer du sein menée à Gustave Roussy.

Dr Barbara Pistilli

Oncologue médicale spécialiste du cancer du sein, la Dr Barbara Pistilli est cheffe du comité de pathologie mammaire à Gustave Roussy.

EN - Villejuif, le 28 septembre 2021

Septembre en or